0 CHECKOUT

OSI Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

  • ID: 2259442
  • January 2013
  • 41 pages
  • MarketLine

OSI Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on OSI Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting OSI Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of OSI Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for OSI Pharmaceuticals, Inc.
- Intelligence on OSI Pharmaceuticals, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about OSI Pharmaceuticals, Inc., such as business expansion, restructuring, and READ MORE >

Note: Product cover images may vary from those shown

Company Snapshot
OSI Pharmaceuticals, Inc.: Company Overview
OSI Pharmaceuticals, Inc.: Overview and Key Facts

OSI Pharmaceuticals, Inc.: Overview

OSI Pharmaceuticals, Inc.: Key Facts
OSI Pharmaceuticals, Inc.: Key Employees
OSI Pharmaceuticals, Inc.: Key Employee Biographies
OSI Pharmaceuticals, Inc.: Major Products and Services
OSI Pharmaceuticals, Inc.: Company History
OSI Pharmaceuticals, Inc.: Key Competitors
OSI Pharmaceuticals, Inc.: Company Analysis
OSI Pharmaceuticals, Inc.: Business Description
OSI Pharmaceuticals, Inc.: SWOT Analysis

OSI Pharmaceuticals, Inc.: SWOT Overview

OSI Pharmaceuticals, Inc.: Strengths

OSI Pharmaceuticals, Inc.: Weaknesses

OSI Pharmaceuticals, Inc.: Opportunities

OSI Pharmaceuticals, Inc.: Threats
OSI Pharmaceuticals, Inc.: Corporate Financial Deals Activity
OSI Pharmaceuticals, Inc.: Financial Deals Overview
OSI Pharmaceuticals, Inc.: Targets and Partners
OSI Pharmaceuticals, Inc.: Top Deals 2008 - 2012YTD-
OSI Pharmaceuticals, Inc.: Advisors

OSI Pharmaceuticals, Inc.: Top Legal Advisors

OSI Pharmaceuticals, Inc.: Top Financial Advisors
OSI Pharmaceuticals, Inc.: Corporate Venturing
OSI Pharmaceuticals, Inc.: Capital Raising
OSI Pharmaceuticals, Inc.: Partnership
OSI Pharmaceuticals, Inc.: Private Equity and Ownership
OSI Pharmaceuticals, Inc.: Recent Developments
OSI Pharmaceuticals, Inc.: News and Events Summary
OSI Pharmaceuticals, Inc.: Business Expansion
OSI Pharmaceuticals, Inc.: Contracts
OSI Pharmaceuticals, Inc.: Financial Deals
OSI Pharmaceuticals, Inc.: Financial Performance
OSI Pharmaceuticals, Inc.: Regulatory and Legal Events
OSI Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: OSI Pharmaceuticals, Inc.: Key Facts
Table 2: OSI Pharmaceuticals, Inc.: Key Employees
Table 3: OSI Pharmaceuticals, Inc.: Key Competitors
Table 4: OSI Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 5: OSI Pharmaceuticals, Inc.: Targets and Partners
Table 6: OSI Pharmaceuticals, Inc.: Top Deals 2008 - 2012YTD-
Table 7: OSI Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 8: OSI Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 9: OSI Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Table 10: OSI Pharmaceuticals, Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Table 11: OSI Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2008 - YTD-2012)
Table 12: OSI Pharmaceuticals, Inc.: Capital Raising by Deal Type (2008 - YTD-2012)
Table 13: OSI Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 14: OSI Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 15: OSI Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2008 - YTD-2012)
Table 16: OSI Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2008 - YTD-2012)
Table 17: OSI Pharmaceuticals, Inc.: News and Events Summary
Table 18: OSI Pharmaceuticals, Inc.: Business Expansion
Table 19: OSI Pharmaceuticals, Inc.: Contracts
Table 20: OSI Pharmaceuticals, Inc.: Financial Deals
Table 21: OSI Pharmaceuticals, Inc.: Financial Performance
Table 22: OSI Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 23: OSI Pharmaceuticals, Inc.: Research & Development

List of Figures

Figure 1: OSI Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 2: OSI Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Figure 3: OSI Pharmaceuticals, Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Figure 4: OSI Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2008 - YTD-2012)
Figure 5: OSI Pharmaceuticals, Inc.: Capital Raising by Deal Type (2008 - YTD-2012)
Figure 6: OSI Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 7: OSI Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Figure 8: OSI Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2008 - YTD-2012)
Figure 9: OSI Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2008 - YTD-2012)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.